Is Relaxo Footwears profitable in 2026?

Yes. Relaxo posted FY25 PAT of ₹170 crore (6.1% margin) and Q4 FY26 PAT of ₹68 crore, up 20.4% YoY, on revenue of ₹751 crore for the quarter ended March 31, 2026, per its NSE filings and Q4 earnings release.

Is Relaxo's revenue growing?

Growth has stalled: FY25 revenue fell ~4% YoY to ₹2,790 crore, and FY26 came in roughly flat at ₹2,702-2,748 crore. Q4 FY26 alone rebounded 8.1% YoY on GST-cut tailwinds and restocking, per company filings dated May-June 2026.

Who is Relaxo Footwears' biggest competitor?

Bata India is the named incumbent, holding ~5% retail value share versus Relaxo's ~4% in 2025 per Euromonitor. Bata outsources over 50% of production while Relaxo manufactures ~95% in-house, limiting Bata's ability to contest Relaxo's low-margin chappal segment.

Could AI replace Relaxo Footwears?

Unlikely. Relaxo's moat is physical: ~95% in-house manufacturing and a 70,000-retailer distribution network built over 50 years, both untouchable by AI as of July 2026. AI exposure is limited to e-commerce discovery and marketing, where Relaxo hired a VP-Ecommerce in July 2025.

Is Relaxo a safe stock to buy in 2026?

Mixed. Relaxo is a 50-year-old, family-controlled (70-71% Dua family ownership as of December 2025), profitable manufacturer, but its market cap of roughly ₹10,000-10,230 crore in July 2026 is less than half its 2021 peak above ₹20,600 crore, reflecting demand-recovery uncertainty.

Who owns Relaxo Footwears?

Relaxo is publicly traded on NSE (RELAXO) and BSE (530517) with no parent company; the founding Dua family, led by Chairman Ramesh Kumar Dua, held roughly 70-71% promoter ownership as of December 2025, per company disclosures.

Consumer brands · India

Relaxo Footwears Limited

relaxofootwear.com ↗

Indian mass-market footwear maker behind Hawaii chappals and Sparx sandals.

Defensible for now

Assessed 25 July 2026 · Evidence as of 25 July 2026

Real protection, with named pressure against it.

On the recordSince 25 July 2026 · Checkable from late July/August 2026 · Every call on the record Checkpoint: Q1 FY27 earnings, test of organic demand once GST-cut restocking bump fades

The call

Relaxo keeps its mass-market grip through in-house making and huge retail reach, but growth has stalled while Campus and Metro move faster on premium lines.

Relaxo Footwears makes affordable sandals and shoes in India and has owned its own factories and built a huge network of 70,000 stores over 50 years, which is hard for others to replicate quickly. However, sales have barely grown or shrunk for two years, while competitors like Metro and Campus are growing faster, and rival Bata can't match Relaxo's cheap sandal business since Bata outsources most of its manufacturing. The key question over the next few quarters is whether Relaxo can actually sell more shoes by moving upmarket and selling online, or if recent sales gains were just temporary tax breaks and store restocking, not real customer demand.

Why

AI pressure: Quick-commerce catalog AI (Blinkit, Zepto, Instamart). AI ranking on quick-commerce apps could favor brands with richer data and premium tags, squeezing Relaxo's low-price catalog visibility. Could AI do the core job? Unlikely.

Bigger players: Bata India. Bata holds slightly more value share and could push into chappals, though its outsourced model makes matching Relaxo's low prices harder. Could a giant copy it? Probably.

What protects it. Owns ~95% of its manufacturing and reaches 70,000 retailers through 650 distributors built over 50 years.

What would change this call

Relaxo's Q1/Q2 FY27 organic volume growth once GST-cut tailwind fades. Shows whether recent revenue gains reflect real demand recovery or a one-off tax/restocking bump.
Sparx's reported share trend in the ₹1,000-2,500 athleisure segment vs Campus and Nike/Adidas. Indicates whether Relaxo is losing its mid-tier growth segment to focused athleisure rivals.
Actual FY27 EBO openings vs the ~100-store guidance and their same-store sales. Tests whether the premiumization/D2C pivot is gaining real traction or falling short of plan.

Key numbers

FY26 revenue ~₹2,702-2,748 crore, roughly flat YoY (2026-03-31)
Q4 FY26 revenue ₹751 crore, up 8.1% YoY (2026-03-31)
Market cap ~₹10,000 crore, down from ₹20,600 crore peak (2026-07-24)

Named risks

Two consecutive years of flat-to-declining revenue (FY25 -4%, FY26 flat) signal fragile mass-market demand recovery. Severity: high
Growth trails premium/athleisure peers Metro Brands and Campus Activewear in FY27 Q1 projections. Severity: medium
Q4 FY26 rebound may be driven by one-off GST cut and distributor restocking rather than sustained organic demand. Severity: medium
Raw material price volatility (PVC, EVA, rubber, PU) poses ongoing margin risk. Severity: medium
Stock trades well below 2021 all-time high, reflecting persistent investor doubt about demand durability. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Bata India	contesting	Bata holds ~5% value share vs Relaxo's 4% in 2025, but outsources >50% production vs Relaxo's ~95% in-house
Metro Brands	losing to	Metro projected 15.7% FY27 Q1 revenue growth vs Relaxo's 10.4%, per Elara estimate dated 2026-07-15
Campus Activewear	losing to	Campus projected 12.2% FY27 Q1 growth vs Relaxo's 10.4%, contesting Sparx athleisure base as of 2026-07-15
Nike and Adidas	losing to	Global sportswear incumbents dominate premium segment adjacent to Relaxo's Sparx brand, per December 2024 analysis
Bata India	gaining on	Bata's projected FY27 Q1 growth of 5.5% trails Relaxo's 10.4%, per July 2026 brokerage note

Questions people ask

Is Relaxo Footwears profitable in 2026?: Yes. Relaxo posted FY25 PAT of ₹170 crore (6.1% margin) and Q4 FY26 PAT of ₹68 crore, up 20.4% YoY, on revenue of ₹751 crore for the quarter ended March 31, 2026, per its NSE filings and Q4 earnings release.
Is Relaxo's revenue growing?: Growth has stalled: FY25 revenue fell ~4% YoY to ₹2,790 crore, and FY26 came in roughly flat at ₹2,702-2,748 crore. Q4 FY26 alone rebounded 8.1% YoY on GST-cut tailwinds and restocking, per company filings dated May-June 2026.
Who is Relaxo Footwears' biggest competitor?: Bata India is the named incumbent, holding ~5% retail value share versus Relaxo's ~4% in 2025 per Euromonitor. Bata outsources over 50% of production while Relaxo manufactures ~95% in-house, limiting Bata's ability to contest Relaxo's low-margin chappal segment.
Could AI replace Relaxo Footwears?: Unlikely. Relaxo's moat is physical: ~95% in-house manufacturing and a 70,000-retailer distribution network built over 50 years, both untouchable by AI as of July 2026. AI exposure is limited to e-commerce discovery and marketing, where Relaxo hired a VP-Ecommerce in July 2025.
Is Relaxo a safe stock to buy in 2026?: Mixed. Relaxo is a 50-year-old, family-controlled (70-71% Dua family ownership as of December 2025), profitable manufacturer, but its market cap of roughly ₹10,000-10,230 crore in July 2026 is less than half its 2021 peak above ₹20,600 crore, reflecting demand-recovery uncertainty.
Who owns Relaxo Footwears?: Relaxo is publicly traded on NSE (RELAXO) and BSE (530517) with no parent company; the founding Dua family, led by Chairman Ramesh Kumar Dua, held roughly 70-71% promoter ownership as of December 2025, per company disclosures.

Timeline

2026-07-14Onboarded Manoj Taneja as VP-Ecommerce to lead D2C and quick-commerce strategy
2026-07-10Rolled out new retail store format with brand zones across 416+ Exclusive Brand Outlets
2026-06-01Reported FY26 revenue roughly flat at ₹2,702-2,748 crore vs FY25
2026-05-29Celebrated 50th anniversary; unveiled Autumn-Winter 2026 collection of 600+ products
2026-03-31Q4 FY26 revenue ₹751 crore (+8.1% YoY), PAT ₹68 crore (+20.4% YoY)
2025-12-20Launched premiumization push into higher price points up to ~₹2,500
2025-09-03GST Council cut footwear tax from 12% to 5% for pairs up to ₹2,500
2025-05-09Reported FY25 revenue ₹2,790 crore, down ~4% YoY, PAT ₹170 crore
1993Converted from private to public limited company
1984Relaxo Footwears incorporated, building on family footwear business dating to 1976

Head to head

Bata India Limited vs Relaxo Footwears Limited Metro Brands Limited vs Relaxo Footwears Limited

Revision history

25 July 2026

First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.

In the same band

Estée Lauder LVMH Moet Hennessy Louis Vuitton Chow Sang Sang Holdings International Limited